Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

University of Minnesota (UMN)

Status: Enrolling

Conditions: Cancer Screening; Transgender; Gender Diverse Populations

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT07075731

2023LS213

Details and patient eligibility

About

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years and older
• Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent
• Able to understand, speak, read, and write in English
• Patients who have undergone hysterectomy, or plan to have a hysterectomy
• Patients who are transgender and gender diverse"

Exclusion criteria

• Opted out of research
• <18 years old
• Lacks capacity to consent/has diminished capacity to consent
• Cannot provide informed consent
• Those on the study's community advisory board

Trial design

40 participants in 3 patient groups

Standard of Care Cancer Screening

Treatment:

Other: No intervention

FDA approved self swab

Treatment:

Other: No intervention

Mock self swab

Treatment:

Other: No intervention